QQ客服 官方微博 反馈留言

	Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients
	Wang, Pingan; Guo, Lingyu; Li, Kaipeng; Ning, Shanglei; Shi, Weichen; Liu, Zhaochen; Chen, Yuxin
刊名	CANCER BIOMARKERS
	2018
卷号	21期号:3页码:681-687
关键词	SRSF2 hepatocellular carcinoma immunohistochemistry clinical pathology
DOI	10.3233/CBM-170770
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4565491
专题	山东大学
作者单位	Shandong Univ, Qilu Hosp, Dept Gen Surg, 107 Wenhuaxi Rd, Jinan 2
推荐引用方式 GB/T 7714	Wang, Pingan,Guo, Lingyu,Li, Kaipeng,et al. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients[J]. CANCER BIOMARKERS,2018,21(3):681-687.
APA	Wang, Pingan.,Guo, Lingyu.,Li, Kaipeng.,Ning, Shanglei.,Shi, Weichen.,...&Chen, Yuxin.(2018).Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.CANCER BIOMARKERS,21(3),681-687.
MLA	Wang, Pingan,et al."Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients".CANCER BIOMARKERS 21.3(2018):681-687.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。